-
'Chemo brain' may stem from damage to the brain's drainage systemAn early-stage study has found that a common chemotherapy drug disrupts lymphatic cells in the tissue surrounding the brain. This is linked to memory issues in mice.
-
COVID-19 mRNA vaccines can trigger the immune system to recognize and kill cancer, research findsThe researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to traditional immunotherapy.
6 Comments -
Could simple blood tests identify cancer earlier?Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?
-
HPV vaccination drives cervical cancer rates down in both vaccinated and unvaccinated peopleResearchers have found that human papillomavirus (HPV) vaccines are highly effective at reducing cervical cancer-causing infections and can offer herd immunity, reinforcing previous research and highlighting the need for a global HPV vaccine rollout.
2 Comments -
Diet change could make brain cancer easier to treat, early study hintsA new lab study exploited a unique aspect of metabolism in glioblastoma to boost the effectiveness of chemoradiation, turning the cancer's properties against itself.
4 Comments -
'Universal' cancer vaccine heading to human trials could be useful for 'all forms of cancer'A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials.
2 Comments -
Planned C-sections linked to increased risk of childhood leukemia in study: What to knowA new study underscores a known link between planned C-sections and the risk of ALL, a childhood cancer. But overall, the risk is still very small, experts caution.
6 Comments -
Why is heart cancer so rare?Studying why heart cells are less likely to become cancerous can provide clues to improving heart regeneration and treatments for heart disease.
-
'PAC-MANN' uses magnets and glowing 'probes' to detect signs of pancreatic cancerA new test called PAC-MANN is designed to detect signs of pancreatic cancer in blood. It's still in development, but the hope is that it will help catch the deadly cancer early.
